Intrommune Therapeutics Appoints Sergi Trilla, MD, MBA to its Scientific and Business Advisory Boards Press Releases / By Intrommune
Research Presentations at the 2021 Annual AAAAI Meeting Highlight Limitations of Current Food Allergy Treatments and Further Validates Intrommune Therapeutics’ Approach Press Releases / By Intrommune
Intrommune Therapeutics Publishes Peanut Allergy and Immunotherapy Report Press Releases / By Intrommune
Intrommune Receives IND Clearance From U.S. Food and Drug Administration for INT301 Press Releases / By Intrommune
Recent Peer-Reviewed Publication Supports Immunotherapy for the Treatment of Food Allergies Press Releases / By Intrommune
Media Alert: Interest in Peanut Allergy Market Heats up in the Wake of Aimmune/Nestlé Deal Press Releases / By Intrommune
